Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Effects of oligo sequence and chemistry on the efficiency of oligodeoxyribonucleotide-mediated mRNA cleavage.
Baker C
,
Holland D
,
Edge M
,
Colman A
.
???displayArticle.abstract???
Using the endogenous histone H4 mRNA of Xenopus oocytes as a target, we have previously shown that 20mer oligos complementary to different parts of this sequence vary in their effectiveness at causing mRNA cleavage in vivo, and that some of the RNA can never be cleaved. In this paper we show that the resistant RNA is not localised within one part of the oocyte, and that the relative resistance in vivo of endogenous or synthetic H4 mRNA to the different oligos is preserved in an in vitro assay system using deproteinised RNA. If an prior annealing step is included in vitro, all resistance is abolished. Chemical modification of one oligo by end substitution with methylphosphonate or phosphorothioate residues did not improve cleavage efficiency. Oligos with complete phosphorothioate substitution cause slower cleavage in vivo but persist for longer. Consequently phosphorothioate oligos are effective at lower doses than phosphodiester ones, provided that the incubation time is long enough (24 hours). Increasing oligo length from 20nt to 30nt increases phosphorothioate oligo efficiency over long reaction times in vivo, but decreases efficiency during short in vitro assays. Similar increases in length did not affect phosphodiester oligo performance in vivo, but caused a decrease in efficiency in vitro which was overcome by an annealing step.
Cazenave,
Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides.
1989, Pubmed,
Xenbase
Cazenave,
Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides.
1989,
Pubmed
,
Xenbase
Cazenave,
Rate of degradation of [alpha]- and [beta]-oligodeoxynucleotides in Xenopus oocytes. Implications for anti-messenger strategies.
1987,
Pubmed
,
Xenbase
Cazenave,
Enzymatic amplification of translation inhibition of rabbit beta-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents.
1987,
Pubmed
,
Xenbase
Clerc,
Transcription of a cloned Xenopus laevis H4 histone gene in the homologous frog oocyte system depends on an evolutionary conserved sequence motif in the -50 region.
1983,
Pubmed
,
Xenbase
Dash,
Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity.
1987,
Pubmed
,
Xenbase
Dumont,
Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals.
1972,
Pubmed
,
Xenbase
Gagnor,
alpha-DNA. VI: Comparative study of alpha- and beta-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition.
1987,
Pubmed
Heikkila,
A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
,
Pubmed
Kressmann,
Transcription of cloned tRNA gene fragments and subfragments injected into the oocyte nucleus of Xenopus laevis.
1978,
Pubmed
,
Xenbase
Lemaitre,
Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site.
1987,
Pubmed
Marcus-Sekura,
Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages.
1987,
Pubmed
McBride,
A new, reliable cartridge for the rapid purification of synthetic DNA.
1988,
Pubmed
Meinkoth,
Hybridization of nucleic acids immobilized on solid supports.
1984,
Pubmed
Melton,
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.
1984,
Pubmed
Minshull,
The use of single-stranded DNA and RNase H to promote quantitative 'hybrid arrest of translation' of mRNA/DNA hybrids in reticulocyte lysate cell-free translations.
1986,
Pubmed
Newton,
Ion-exchange high-performance liquid chromatography of oligodeoxyribonucleotides using formamide.
1983,
Pubmed
Paterson,
Structural gene identification and mapping by DNA-mRNA hybrid-arrested cell-free translation.
1977,
Pubmed
Sagata,
Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes.
1988,
Pubmed
,
Xenbase
Shibahara,
Site-directed cleavage of RNA.
1987,
Pubmed
Shuttleworth,
Antisense oligodeoxyribonucleotide-directed cleavage of maternal mRNA in Xenopus oocytes and embryos.
1988,
Pubmed
,
Xenbase
Shuttleworth,
Antisense oligonucleotide-directed cleavage of mRNA in Xenopus oocytes and eggs.
1988,
Pubmed
,
Xenbase
Smith,
Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.
1986,
Pubmed
Smith,
Destruction of a translationally controlled mRNA in Xenopus oocytes delays progesterone-induced maturation.
1988,
Pubmed
,
Xenbase
Stein,
Physicochemical properties of phosphorothioate oligodeoxynucleotides.
1988,
Pubmed
Stephenson,
Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.
1978,
Pubmed
Verspieren,
An acridine-linked oligodeoxynucleotide targeted to the common 5' end of trypanosome mRNAs kills cultured parasites.
1987,
Pubmed
Walder,
Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.
1988,
Pubmed
Wickstrom,
Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.
1988,
Pubmed
Zamecnik,
Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.
1986,
Pubmed
Zinn,
Identification of two distinct regulatory regions adjacent to the human beta-interferon gene.
1983,
Pubmed
